Загрузка...
Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
Alzheimer’s disease (AD) is of great cause for concern in our ageing population, which currently lacks diagnostic tools to permit accurate and timely diagnosis for affected individuals. The development of such tools could enable therapeutic interventions earlier in the disease course and thus potent...
Сохранить в:
| Опубликовано в: : | Medicines (Basel) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789538/ https://ncbi.nlm.nih.gov/pubmed/31484367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicines6030092 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|